GGrantIndex
Sort

326,823 grants matching clinical trial

Clinical Development of 4-Cl-KYN to Treat Pain

$2,469,281
Ralph Snodgrass · Vistagen Therapeutics, Inc. · R44 · FY2009 · DA

Lentiviral Gene Therapy for Sickle Cell Disease and Immunodeficiency Disorders

$2,469,009
Brian P Sorrentino · St. Jude Children'S Research Hospital · P01 · FY2010 · HL

Foamy Viral Gene Therapy for X-linked Severe Combined Immune Deficiency

$2,468,981
David J Rawlings · Seattle Children'S Hospital · P01 · FY2015 · AI

Carbohydrate-based Therapy for Lung Disease

$2,468,866
John V Fahy · University Of California, San Francisco · P01 · FY2017 · HL

Pitt-Ohio State Clinical Trials Unit

$2,468,833
John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2023 · AI

Institute for Integration of Medicine & Science: A Partnership to Improve Health

$2,468,749
Robert A Clark · University Of Texas Hlth Science Center · UL1 · FY2013 · TR

Foamy Viral Gene Therapy for X-linked Severe Combined Immune Deficiency

$2,468,421
David J Rawlings · Seattle Children'S Hospital · P01 · FY2016 · AI

TAS::75 0850::TAS RECOVERY ACT ACTNOW CLINICAL TRIAL SUPPORT - CTEP IT Support

$2,468,393
Sudhir Raju · Ctis, Inc. · N02 · FY2009 · CA

Implementing genomic medicine through pragmatic trials in diverse and underserved populations across Indiana.

$2,468,344
Todd C. Skaar · Indiana University Indianapolis · U01 · FY2020 · HG

COG NCTN Year 9 BIQSFP Supplement & Progress Report

$2,468,151
Douglas S. Hawkins · Public Health Institute · U10 · FY2022 · CA

Molecular Diagnostics Core Laboratory

$2,468,096
Liqiang Xi · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA

From cells to complex syndromes: using networks to understand heterogeneity in TDP-related frontotemporal degeneration and aging

$2,467,715
Murray Grossman · University Of Pennsylvania · P01 · FY2021 · AG

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,467,614
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2023 · CA

Cancer Center Support Grant

$2,467,468
Thomas P Loughran · University Of Virginia · P30 · FY2015 · CA

Vaccines for prescription opioid and heroin abuse

$2,467,399
Paul Pentel · Hennepin Healthcare Research Institute · U01 · FY2015 · DA

Sickle cell disease molecular pathogenesis and drug therapy

$2,467,359
William Eaton · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Center for Pre-Clinical Cancer Research

$2,467,250
Joseph Francis · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM

Measurement of HIV Neutralization Using Quantitative Assays

$2,467,107
John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Improving IVF Success through Multiplexed Optical Metabolic Imaging

$2,466,980
Haohua Tu · University Of Illinois At Urbana-Champaign · R01 · FY2025 · HD

Cardiovascular Disease and Diabetes Program Project

$2,466,716
Karin E. Bornfeldt · University Of Washington · P01 · FY2017 · HL

UCCRC--CANCER CENTER SUPPORT GRANT

$2,466,698
University Of Chicago · P30 · FY2000 · CA

Genomics for Kidney Transplantation

$2,466,342
Daniel Rene Salomon · Scripps Research Institute, The · U19 · FY2006 · AI

Canadian Cancer Trials Group - Canadian Collaborating Clinical Trials Network: Clinical Trials Development & Member Site Core

$2,466,309
Janet Ellen Dancey · Queen'S University At Kingston · U10 · FY2020 · CA

Alzheimer's Disease Research Center at Columbia University

$2,465,772
Michael Shelanski · Columbia University Health Sciences · P50 · FY2010 · AG

GENE THERAPY FOR SICKLE CELL ANEMIA

$2,465,735
Albert Einstein Col Of Med Yeshiva Univ · P01 · FY2004 · HL